FDA Grants Permission For Export of Antigenics Inc. (New York)’ Oncophage(R) to Russia

NEW YORK--(BUSINESS WIRE)--Antigenics Inc. (NASDAQ: AGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted the necessary permission to allow for the export of Oncophage ® (vitespen) to Russia.

MORE ON THIS TOPIC